Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION (Tables)

v3.24.1.u1
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Schedule of stock option activity
                       
    Common Stock Options  
    Shares     Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Life in years
    Intrinsic Value  
Outstanding at January 1, 2024     19,066     $ 407.97                  
Granted     45     $ 4.50                  
Forfeited     (4,699 )   $ 485.28                  
Exercised         $ 0.00                  
Outstanding at March 31,2024     14,412     $ 381.55       8.40     $ 0.00  
Exercisable at March 31, 2024     7,691     $ 528.26       7.85     $ 0.00  
Schedule of assumptions
               
    2024     2023  
Volatility (based on the Company’s volatility in 2024 and peer companies in 2023)     170%       79% - 83%  
Risk free interest rate     4.5%       3.54% - 4.77%  
Dividends     None       None  
Estimated life in years     6       6  
Schedule of stock-based compensation expense
           
   

Three Months
Ended

March 31,

2024

   

Three Months
Ended

March 31,

2023

 
Cost of Goods Sold   $ (10,642 )   $ 206,477  
Sales and Marketing     (55,071 )     311,759  
Product Development     42,604       208,594  
General and Administrative     21,187       303,605  
Total   $ (1,922 )   $ 1,057,435